- Home
- CTXR vs CLRB Comparison
CTXR vs CLRB Comparison
Compare CTXR & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- CLRB
- Stock Information
- Founded
- CTXR 2007
- CLRB 2002
- Country
- CTXR United States
- CLRB United States
- Employees
- CTXR N/A
- CLRB N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- CTXR Health Care
- CLRB Health Care
- Exchange
- CTXR Nasdaq
- CLRB Nasdaq
- Market Cap
- CTXR 14.6M
- CLRB 12.5M
- IPO Year
- CTXR N/A
- CLRB N/A
- Fundamental
- Price
- CTXR $1.58
- CLRB $7.90
- Analyst Decision
- CTXR Strong Buy
- CLRB Hold
- Analyst Count
- CTXR 3
- CLRB 2
- Target Price
- CTXR $53.00
- CLRB N/A
- AVG Volume (30 Days)
- CTXR 6.8M
- CLRB 1.3M
- Earning Date
- CTXR 08-11-2025
- CLRB 08-12-2025
- Dividend Yield
- CTXR N/A
- CLRB N/A
- EPS Growth
- CTXR N/A
- CLRB N/A
- EPS
- CTXR N/A
- CLRB N/A
- Revenue
- CTXR N/A
- CLRB N/A
- Revenue This Year
- CTXR N/A
- CLRB N/A
- Revenue Next Year
- CTXR N/A
- CLRB N/A
- P/E Ratio
- CTXR N/A
- CLRB N/A
- Revenue Growth
- CTXR N/A
- CLRB N/A
- 52 Week Low
- CTXR $0.65
- CLRB $6.50
- 52 Week High
- CTXR $26.25
- CLRB $94.50
- Technical
- Relative Strength Index (RSI)
- CTXR 68.44
- CLRB 40.04
- Support Level
- CTXR $0.76
- CLRB $9.60
- Resistance Level
- CTXR $1.45
- CLRB $10.19
- Average True Range (ATR)
- CTXR 0.31
- CLRB 1.57
- MACD
- CTXR 0.06
- CLRB -0.50
- Stochastic Oscillator
- CTXR 47.63
- CLRB 11.58
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.